Liminatus Pharma, Inc. Class A Common Stock (LIMN) is a publicly traded Healthcare sector company. As of September 4, 2026, LIMN trades at $3.71 with a market cap of $5.16M and a P/E ratio of -8.73. LIMN moved -2.73% today. Year to date, LIMN is -88.01%; over the trailing twelve months it is -97.42%. Its 52-week range spans $3.42 to $1,683.00. Rallies surfaces LIMN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for LIMN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $3.71 |
| Market Cap | $5.16M |
| P/E Ratio | -8.73 |
| EPS | $-0.43 |
| Dividend Yield | 0.00% |
| 52-Week High | $1,683.00 |
| 52-Week Low | $3.42 |
| Volume | 22.02K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.21M |
| Gross Margin | 0.00% |
LIMN analyst coverage data. Average price target: $0.00.